Amlodipine/celecoxib

Amlodipine/celecoxib, sold under the brand name Consensi, is a medication used to treat osteoarthritis in adults.[1] It is a fixed-dose combination of amlodipine besylate and celecoxib.[1] It is taken by mouth.[1]

Amlodipine/celecoxib
Combination of
AmlodipineCalcium channel blocker
CelecoxibNonsteroidal anti-inflammatory drug (NSAID)
Clinical data
Trade namesConsensi
AHFS/Drugs.comProfessional Drug Facts
License data
Routes of
administration
By mouth
ATC code
Legal status
Legal status
Identifiers
CAS Number
UNII
KEGG

The most common side effects include edema, abdominal pain, diarrhea, dyspepsia, flatulence, peripheral edema, accidental injury, dizziness, pharyngitis, rhinitis, sinusitis, upper respiratory tract infection, and rash.[1]

It was approved for use in the United States in May 2018.[2]

Medical uses

Amlodipine/celecoxib is indicated for use in adults for whom treatment with amlodipine for hypertension and celecoxib for osteoarthritis are appropriate.[1]

History

Amlodipine/celecoxib was approved for use in the United States in May 2018.[2]

References

  1. "Consensi- amlodipine besylate and celecoxib tablet". DailyMed. 17 December 2019. Retrieved 14 May 2020.
  2. "Drug Approval Package: Consensi (amlodipine and celecoxib)". U.S. Food and Drug Administration (FDA). 29 November 2018. Retrieved 14 May 2020.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.